BBI Solutions are supporting EQA Schemes in pursuit of accurate diagnostic results

In a drive to support accurate results within the in-vitro diagnostics (IVD) industry, BBI Solutions are offering a 10% discount across their product range for all external quality assessment (EQA) schemes.
Spread the Word
Listed Under

* Ivd
* Assay
* Enzyme
* Pharmaceutical

* Medical
* Science

* Llanishen - Cardiff - Wales

* Deals

LLANISHEN, Wales - March 7, 2014 - PRLog -- External Quality Assessment (EQA) is defined by the World Health Organisation as ‘a system of objectively checking laboratory results by means of an external agency’. This independent checking is coordinated by EQA schemes, which manufacture identical control samples and distribute them to diagnostic laboratories on a local and global scale. The laboratories then test the sample in the same way as they would a normal patient and then return the results to the EQA assessment centre. The EQA assessment centre collates hundreds of results to determine the accuracy of the individual laboratories participating in the scheme. The scheme then provides continual training, feeding into large quality management systems to drive improved processes across the board.

To manufacture these control samples, EQA schemes acwej require blood based biological materials, for example Hepatitis B positive human serum, or human plasma with elevated levels of thyroid peroxidase antibodies. BBI Solutions operate direct collection facilities in multiple countries to support the IVD industry with these essential raw materials.

Ensuring that results for disease diagnosis and management are always accurate runs parallel to the BBI Group vision - ‘a world where everyone has the opportunity for a better quality of life.’ To support the work that EQA Schemes undertake to achieve this, BBI Solutions are offering a 10% discount to help support and create awareness of this essential group within the IVD Industry.


BBI Solutions is a leading manufacturer of raw materials and finished test platforms for the in-vitro diagnostics and pharmaceutical markets. Founded in 1986 by John Chandler of Cardiff University, BBI has grown from a small specialist company to a global business with manufacturing sites spanning four countries.

Our range of raw materials includes human antigens, antibodies, serum and plasma products and clinical chemistry enzymes. We manufacture world renowned labels for lateral flow, ELISA assay and biosensors, including our gold nanoparticles and glucose oxidase.

BBI Solutions offer contract development and manufacturing services with a core focus on gold conjugation and lateral flow test manufacture

BBI Solutions is part of the BBI Group.

Media Contact
Zoe Williams
Email:*** Email Verified
Tags:Ivd, Assay, Enzyme, Pharmaceutical
Industry:Medical, Science
Location:Llanishen - Cardiff - Wales
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
BBI Solutions News
Daily News
Weekly News

Like PRLog?
Click to Share